March 05, 2015 1:53 PM ET

Biotechnology

Company Overview of BioMarck Pharmaceuticals, Ltd.

Company Overview

BioMarck Pharmaceuticals, Ltd., a biopharmaceutical company, engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders associated with the over-secretion of mucus and pulmonary inflammation. The company’s lead product is BIO-11006, a novel treatment for chronic obstructive pulmonary disease (COPD). Its BIO-11006 inhibits the function of the myristoylated alanine rich C kinase substrate (MARCKS) protein, which is the vital component for secretion of mucus and inflammatory mediators. The company was founded in 2002 and is based in Durham, North Carolina.

Westpark Corporate Center

4364 South Alston Avenue

Durham, NC 27713-2280

United States

Founded in 2002

Phone:

919-539-2288

Fax:

919-881-8488

Key Executives for BioMarck Pharmaceuticals, Ltd.

Co-Founder, Chairman of the Scientific Advisory Board, Chief Executive Officer, President and Director
Co-Founder and Vice Chairman of the Board
Co-Founder and Director
Co-Founder, Chief Scientist and Member of Scientific Advisory Board
Vice President of Research & Development
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Flower Genetics LLC United States
Zumbro Discovery, Inc. United States
CAMgate United States
Nortis Inc. United States
AGY Therapeutics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BioMarck Pharmaceuticals, Ltd., please visit www.biomarck.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.